Get the Stockscreener App
21.85
3.28%
-0.74
After Hours:
21.85
Assembly Biosciences Inc stock is traded at $21.85, with a volume of 67,503.
It is down -3.28% in the last 24 hours and down -8.92% over the past month.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
See More
Previous Close:
$22.59
Open:
$22.49
24h Volume:
67,503
Relative Volume:
0.77
Market Cap:
$167.64M
Revenue:
-
Net Income/Loss:
$-61.23M
P/E Ratio:
-1.6162
EPS:
-13.5194
Net Cash Flow:
$22.49M
1W Performance:
-8.25%
1M Performance:
-8.92%
6M Performance:
+97.92%
1Y Performance:
+21.12%
1-Day Range:
$21.66
$22.93
1-Week Range:
$21.66
$25.32
52-Week Range:
$7.75
$27.17
Assembly Biosciences Inc Stock (ASMB) Company Profile
Name
Assembly Biosciences Inc
Sector
Industry
Phone
(833) 409-4583
Address
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Compare ASMB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
21.85 | 170.78M | 0 | -61.23M | 22.49M | -13.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-18-25 | Resumed | H.C. Wainwright | Buy |
| Mar-25-25 | Initiated | Guggenheim | Buy |
| Sep-20-24 | Upgrade | Jefferies | Hold → Buy |
| Sep-13-21 | Initiated | H.C. Wainwright | Neutral |
| Sep-02-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Mar-23-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Nov-06-20 | Downgrade | Jefferies | Buy → Hold |
| Oct-19-20 | Initiated | Truist | Buy |
| Oct-16-19 | Initiated | Mizuho | Buy |
| Nov-19-18 | Initiated | Leerink Partners | Outperform |
| Oct-08-18 | Upgrade | B. Riley FBR | Neutral → Buy |
| Aug-08-18 | Initiated | Robert W. Baird | Outperform |
| Apr-13-18 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jan-05-18 | Initiated | B. Riley FBR, Inc. | Neutral |
| Nov-08-17 | Initiated | Jefferies | Buy |
| May-30-17 | Initiated | Chardan Capital Markets | Buy |
View All
Assembly Biosciences Inc Stock (ASMB) Latest News
How sentiment analysis helps forecast Assembly Biosciences Inc.Earnings Trend Report & Weekly Return Optimization Alerts - Newser
What does recent volatility data suggest for Assembly Biosciences Inc.Trade Analysis Report & Momentum Based Trading Ideas - Newser
Real time pattern detection on Assembly Biosciences Inc. stockJuly 2025 Fed Impact & AI Based Buy and Sell Signals - Newser
Comparing Assembly Biosciences Inc. in custom built stock radarsMarket Risk Summary & Entry Point Confirmation Alerts - Newser
Price action breakdown for Assembly Biosciences Inc.2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - Newser
11,799 Shares in Assembly Biosciences, Inc. $ASMB Bought by American Century Companies Inc. - MarketBeat
Is Assembly Biosciences Inc. reversing from oversold territoryGold Moves & Risk Managed Investment Signals - Newser
Will earnings trigger a reversal in Assembly Biosciences Inc.Trade Volume Report & Risk Controlled Stock Pick Alerts - Newser
Analyzing recovery setups for Assembly Biosciences Inc. investors2025 Stock Rankings & Real-Time Volume Triggers - Newser
Custom watchlist performance reports with Assembly Biosciences Inc.Trade Analysis Report & Weekly High Return Stock Forecasts - Newser
Is Assembly Biosciences Inc. stock reversal real or fakeEarnings Miss & Community Supported Trade Ideas - Newser
Relative strength of Assembly Biosciences Inc. in sector analysisCPI Data & Capital Protection Trade Alerts - Newser
What data driven models say about Assembly Biosciences Inc.’s futureMarket Growth Report & Safe Swing Trade Setups - Newser
How moving averages guide Assembly Biosciences Inc. tradingJuly 2025 Selloffs & Reliable Trade Execution Plans - Newser
Multi asset correlation models including Assembly Biosciences Inc.July 2025 Analyst Calls & Community Verified Watchlist Alerts - Newser
Is Assembly Biosciences Inc. building a consolidation baseQuarterly Trade Report & Low Risk Entry Point Guides - Newser
Is this a good reentry point in Assembly Biosciences Inc.Market Growth Review & Weekly Watchlist for Hot Stocks - Newser
Guggenheim Issues Positive Forecast for Assembly Biosciences (NASDAQ:ASMB) Stock Price - MarketBeat
Risk adjusted return profile for Assembly Biosciences Inc. analyzedMarket Activity Recap & Community Verified Watchlist Alerts - Newser
How to escape a deep drawdown in Assembly Biosciences Inc.Market Growth Summary & Capital Protection Trading Alerts - Newser
Volatility clustering patterns for Assembly Biosciences Inc.Weekly Market Summary & Low Drawdown Investment Ideas - Newser
Earnings visualization tools for Assembly Biosciences Inc.Earnings Growth Summary & Growth-Oriented Investment Plans - Newser
Using R and stats models for Assembly Biosciences Inc. forecastingInflation Watch & Low Volatility Stock Recommendations - Newser
Assembly Biosciences (NASDAQ:ASMB) Price Target Raised to $39.00 at Guggenheim - Defense World
Automated trading signals detected on Assembly Biosciences Inc.July 2025 Pullbacks & Daily Stock Trend Watchlist - Newser
Intraday pattern recognizer results for Assembly Biosciences Inc.Quarterly Performance Summary & Expert Curated Trade Ideas - Newser
How institutional ownership impacts Assembly Biosciences Inc. stock2025 Market Trends & Real-Time Buy Zone Alerts - Newser
American Century Companies Inc. Buys Shares of 11,799 Assembly Biosciences, Inc. $ASMB - Defense World
What candlestick patterns are forming on Assembly Biosciences Inc.2025 Sector Review & Safe Investment Capital Preservation Plans - Newser
Quantitative breakdown of Assembly Biosciences Inc. recent moveAnalyst Upgrade & Growth Oriented Trading Recommendations - Newser
Can you recover from losses in Assembly Biosciences Inc.Weekly Trade Report & Verified Stock Trade Ideas - Newser
How does Assembly Biosciences Inc. perform in inflationary periods2025 Technical Patterns & Reliable Volume Spike Trade Alerts - beatles.ru
Published on: 2025-09-08 14:59:29 - beatles.ru
Assembly Biosciences Inc Stock (ASMB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):